-+ 0.00%
-+ 0.00%
-+ 0.00%

Starling Oncology Narrows FY2026 Sales Guidance from $650.000M-$670.000M to $650.000M-$660.000M vs $663.685M Est

Benzinga·11/05/2026 22:25:14
Listen to the news
Starling Oncology (NASDAQ:STLN) narrows FY2026 sales outlook from $650.000 million-$670.000 million to $650.000 million-$660.000 million vs $663.685 million estimate.